The epidemiology of the first described carbapenem-resistant Klebsiella pneumoniae outbreak in a tertiary care hospital in Saudi Arabia: How far do we go?

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 8, 2012, Pages 1901-1909

  Balkhy, H H ^a,b   El Saed, A ^a,b   Al Johani, S M ^a,b   Francis, C ^a   Al Qahtani, A A ^c,d   Al Ahdal, M N ^c   Altayeb, H T ^b   Arabi, Y ^a,b   Alothman, A ^a,b   Sallah, M ^a  

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^b KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^c KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^d KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIANAEROBIC AGENT; ANTIINFECTIVE AGENT; CARBAPENEM; CEPHALOSPORIN DERIVATIVE; COLISTIN; GLYCYLCYCLINE DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TIGECYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CARBAPENEM RESISTANT KLEBSIELLA PNEUMONIAE; CARBAPENEM RESISTANT KLEBSIELLA PNEUMONIAE INFECTION; CLINICAL ARTICLE; DISEASE SURVEILLANCE; EPIDEMIC; FEMALE; HUMAN; INFECTION CONTROL; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LENGTH OF STAY; MALE; MICROBIAL COLONIZATION; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSED FIELD GEL ELECTROPHORESIS; RETROSPECTIVE STUDY; SAUDI ARABIA; TERTIARY HEALTH CARE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CARBAPENEMS; CLUSTER ANALYSIS; CROSS INFECTION; DISEASE OUTBREAKS; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GENOTYPE; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; MOLECULAR TYPING; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; SAUDI ARABIA; SURVIVAL ANALYSIS; TERTIARY CARE CENTERS; YOUNG ADULT;

EID: 84866432447     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1519-0     Document Type: Article

References (27)

1. Queenan AM, Bush K (2007) Carbapenemases: the versatile betalactamases. Clin Microbiol Rev 20(3):440-458, table of contents
2. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, Alberti S, Bush K, Tenover FC (2001) Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 45(4):1151-1161 (Pubitemid 32230996)
3. Srinivasan A, Patel JB (2008) Klebsiella pneumoniae carbapenemaseproducing organisms: an ounce of prevention really is worth a pound of cure. Infect Control Hosp Epidemiol 29(12):1107-1109
4. Wei ZQ, Du XX, Yu YS, Shen P, Chen YG, Li LJ (2007) Plasmidmediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob Agents Chemother 51(2):763-765 (Pubitemid 46185304)
5. Naas T, Levy M, Hirschauer C, Marchandin H, Nordmann P (2005) Outbreak of carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a tertiary care hospital of Papeete, French Polynesia. J Clin Microbiol 43(9):4826-4829 (Pubitemid 41298286)
6. Leavitt A, Navon-Venezia S, Chmelnitsky I, Schwaber MJ, Carmeli Y (2007) Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital. Antimicrob Agents Chemother 51(8):3026-3029 (Pubitemid 47206254)
7. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP (2008) Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 29(12):1099-1106
8. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK; National Healthcare Safety Network Team; Participating National Healthcare Safety Network Facilities (2008) NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 29(11):996-1011
9. Centers for Disease Control and Prevention (CDC) (2009) Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep 58(10):256-260
10. Nordmann P, Cuzon G, Naas T (2009) The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 9(4):228-236
11. Clinical and Laboratory Standards Institute (CLS) (2009) Performance standards for antimicrobial susceptibility testing. Nineteenth information supplement (M100-S19). CLSI, Wayne, PA
12. Cohen Stuart J, Leverstein-Van Hall MA; Dutch Working Party on the Detection of Highly Resistant Microorganisms (2010) Guideline for phenotypic screening and confirmation of carbapenemases in Enterobacteriaceae. Int J Antimicrob Agents 36(3):205-210
13. Alaidan A, Bohol MF, Al-Thawadi SI, Al-Suwaine A, Al-Qahtani AA, Al-Ahdal MN (2009) Rapid PFGE method for fingerprinting of Serratia marcescens isolates. JMicrobiolMethods 78(2):238-241
14. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33 (9):2233-2239
15. Ben-David D, Maor Y, Keller N, Regev-Yochay G, Tal I, Shachar D, Zlotkin A, Smollan G, Rahav G (2010) Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection. Infect Control Hosp Epidemiol 31(6):620-626
16. Gardam MA, Burrows LL, Kus JV, Brunton J, Low DE, Conly JM, Humar A (2002) Is surveillance for multidrug-resistant enterobacteriaceae an effective infection control strategy in the absence of an outbreak? J Infect Dis 186(12):1754-1760 (Pubitemid 35463508)
17. Kochar S, Sheard T, Sharma R, Hui A, Tolentino E, Allen G, Landman D, Bratu S, Augenbraun M, Quale J (2009) Success of an infection control program to reduce the spread of carbapenemresistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol 30(5):447-452
18. Laurent C, Rodriguez-Villalobos H, Rost F, Strale H, Vincent JL, Deplano A, Struelens MJ, Byl B (2008) Intensive care unit outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae controlled by cohorting patients and reinforcing infection control measures. Infect Control Hosp Epidemiol 29 (6):517-524 (Pubitemid 351918030)
19. Munoz-Price LS, Hayden MK, Lolans K, Won S, Calvert K, Lin M, Stemer A, Weinstein RA (2010) Successful control of an outbreak of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae at a long-term acute care hospital. Infect Control Hosp Epidemiol 31(4):341-347
20. Castanheira M, Sader HS, Deshpande LM, Fritsche TR, Jones RN (2008) Antimicrobial activities of tigecycline and other broadspectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program. Antimicrob Agents Chemother 52(2):570-573 (Pubitemid 351170830)
21. Bratu S, Tolaney P, Karumudi U, Quale J, Mooty M, Nichani S, Landman D (2005) Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents. J Antimicrob Chemother 56 (1):128-132 (Pubitemid 41418346)
22. Tóth A, Damjanova I, Puskás E, Jánvári L, Farkas M, Dobák A, Böröcz K, Pászti J (2010) Emergence of a colistin-resistant KPC- 2-producing Klebsiella pneumoniae ST258 clone in Hungary. Eur J Clin Microbiol Infect Dis 29(7):765-769
23. Lee J, Patel G, Huprikar S, Calfee DP, Jenkins SG (2009) Decreased susceptibility to polymyxin B during treatment for carbapenemresistant Klebsiella pneumoniae infection. J Clin Microbiol 47 (5):1611-1612
24. Peterson LR (2008) A review of tigecycline - the first glycylcycline. Int J Antimicrob Agents 32(Suppl 4):S215-S222
25. Borer A, Saidel-Odes L, Riesenberg K, Eskira S, Peled N, Nativ R, Schlaeffer F, Sherf M (2009) Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia. Infect Control Hosp Epidemiol 30(10):972-976
26. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y (2008) Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 52(3):1028-1033 (Pubitemid 351358384)
27. Hussein K, Sprecher H, Mashiach T, Oren I, Kassis I, Finkelstein R (2009) Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol 30(7):666-671